Published on in Vol 8, No 4 (2019): Oct-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/15218, first published
.
![Dermatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study Dermatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study](https://asset.jmir.pub/assets/62a59cb5b575538129a2ae496b1a19e4.png 480w,https://asset.jmir.pub/assets/62a59cb5b575538129a2ae496b1a19e4.png 960w,https://asset.jmir.pub/assets/62a59cb5b575538129a2ae496b1a19e4.png 1920w,https://asset.jmir.pub/assets/62a59cb5b575538129a2ae496b1a19e4.png 2500w)
Journals
- Murtagh P, Murphy M, Smyth A, McElnea E, Fahy G. Improving ophthalmic screening for hydroxychloroquine associated retinopathy. Expert Review of Ophthalmology 2021;16(2):133 View
- Fett N, Werth V. A Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials. JAMA Dermatology 2021;157(9):1112 View
- Somisetty S, Santina A, Sarraf D, Mieler W. The Impact of Systemic Medications on Retinal Function. Asia-Pacific Journal of Ophthalmology 2023;12(2):115 View
- Alghamdi A, AlQefari G, Alduraibi K, Al-Amer M, Alharbi B, Alqefari A, Alqifari H, Alhameedy M. Dermatologists’ and Rheumatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study. Cureus 2024 View